Orion Diagnostica specialises in accurate and affordable clinical diagnostic and hygiene monitoring tests, which are easy to use and provide fast results.
We focus on point-of-care diagnostic tools that enable healthcare professionals to detect diseases more quickly, make evidence-based diagnoses and treatment decisions, and follow up on treatment outcomes.
Our flagship product, the QuikRead go® System, measures C-reactive protein (CRP) from a small finger-stick blood sample and gives a result in only two minutes. Clinicians can use CRP tests during patient visits to help them to differentiate between bacterial and viral infections and target antibiotic treatment. The QuikRead go range includes following tests: CRP, CRP+Hb, Strep A, and iFOBT (faecal occult blood).
The Orion GenRead® System built on SIBA®, a rapid and reliable isothermal nucleic acid amplification technology, is our newest platform. The first-phase tests will target pathogens causing gastrointestinal disease. In the future, the product portfolio will cover a wider range of pathogen tests.
Our hygiene monitoring tests enable companies and institutions to detect contamination by micro-organisms and product residues and to monitor the effectiveness of cleaning and disinfection practices.
We sell our own products to global customers through our sales offices and a distributor network covering more than 60 countries. Additionally, we also distribute products by other well-established diagnostics manufacturers.
Orion Diagnostica has ca 300 employees. We have full compliance with ISO 9001 and ISO 13485 Quality Standards as well as FDA requirements.
Orion Diagnostica is part of Orion Group, the leading healthcare company in Finland, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. With 100-year history, Orion is committed to enhancing quality of care and building well-being in the community.